Hence then, the article about phanes therapeutics announces first patient dosed in phase 1 study of pt886 for advanced gastric gastroesophageal junction and pancreatic adenocarcinomas was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT886 for Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinomas )
Last updated :
Also on site :
- Skip Ballet Flats, Jane Fonda Proved This Elevated Shoe Will Take Over Spring 2026
- Exclusive: Anthropic acknowledges testing new AI model representing ‘step change’ in capabilities, after accidental data leak reveals its existence
- Montana Senate candidate says he will introduce bill to draft Graham if elected